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Alzheimer’s disease (AD) is the most common form of dementia in the U.S., accounting 
for 5.4 million cases in 2011(Alzheimer’s Association [AA], 2011). Left untreated, the number 
of people afflicted by AD is expected to increase fourfold by 2050 (Bassil & Grossberg, 2009). 
According to the American Psychiatric Association (2000), AD is a deteriorating  
neurodegenerative disorder characterized by cognitive deficits, including amnesia [memory 
loss], apraxia [inability to carry out motor activities], agnosia [inability to recognize objects], 
aphasia [disturbances in language] and loss of executive function [high-level abilities that 
influence basic abilities] (American Psychiatric Association,2000). Currently, there are no 
recommended prevention strategies for AD; instead, treatments work towards improving 
symptoms or stabilizing cognitive decline for a few months to a few years. Therefore, attempts to 
identify strategies aimed at prevention remain a key approach for this rapid growing disease 
(Bassil & Grossberg, 2009). 
Primary, secondary and tertiary interventions are needed for prevention and protection 
from many health problems. Primary prevention is an important factor in delaying the onset, and 
sometimes preventing many chronic diseases and health conditions. The goal of secondary 
prevention is to ameliorate the effects of illness or injury, while tertiary prevention aims to 
improve patients’ quality of life in the disease state (Nadloo & Wills, 2000). A role of the 
primary care provider, specifically advanced practice nurses (APN), is to focus on prevention 
and wellness care, emphasizing primary and secondary preventive strategies. The treatment and 
management of chronic illnesses are the goals of tertiary prevention. Current research suggests, 
in the case of AD, that exercise may be an effective approach in primary, secondary and tertiary 






The purpose of this paper is to review, synthesize, and analyze current studies on the 
effects physical exercise has on lowering the risk for developing AD. It will examine how 
routine exercise may prevent or attenuate the symptoms of AD in the elderly.  
Epidemiology 
Americans are living longer, and this longevity contributes to a rise in age-related 
diseases, such as AD. According to the Alzheimer’s Disease Facts and Figures (2011), an 
estimated 5.4 million Americans 65 years and older have AD; 13% of the population in that age 
group. The greatest proportional increase in incidence rates of AD and dementia occurs between 
the ages of 75 to 84 years (AA, 2011). In 2010, about 2.4 million people 85 years and older 
(approximately 47% of AD cases) were afflicted with AD. By 2030, the disease is estimated to 
reach 7.7 million Americans aged 65 and older (AA, 2011). 
The Discovery of AD 
While age-related mental deterioration has been recognized throughout history, it was not 
until 1906 when Alois Alzheimer, a German physician, labeled it as a disease. He noted a unique 
type of mental deterioration in his patients. This type of cognitive decline differed from senile 
dementia in that it occurred in the sixth decade of life, with the presence of focal symptoms such 
as aphasia, apraxia, agnosia, severe psychosis, and consequential rapid progression of the 
disease. From autopsies of these patients Alzheimer found neurodegeneration and numerous 
senile plaques in the brain.  In addition, he discovered almost one-third of the cortical cells had 
lysed. In 1910, Alzheimer’s director, Emil Kraepelin coined the term “Alzheimer’s disease,” a 







Neurofibrillary tangles and amyloid plaques, found primarily in the basal forebrain, 
amygdala, hippocampus, and the cerebral cortex, are the primary brain abnormalities seen on 
autopsy in patients with AD.  Neurofibrillary tangles occur when microtubular structures in the 
axon process of a neuron are loosened as a result of the dysfunction of tau proteins. The loosened 
microtubules create tangles, which disrupt cell function and cause the entire neuron to die. 
Neuritic amyloid plaques occur when amyloid precursor proteins split forming protein beta 
amyloid (A-beta). The A-beta breaks apart from the cell membrane and dissolves into fluid 
surrounding the neuron. The non-dissolving A-beta folds, called fibrils and create clusters that 
form plaques. While a small amount of plaque formation is a normal aging process of the human 
brain, in the AD-afflicted brain, the plaques displace brain cells and initiate an inflammatory 
response, which damages cell interiors, resulting in cell lysis (Uphold & Graham, 2003). Cell 
regeneration, or neurogenesis, can correct the loss of some of the lysed neuronal cells, but not all. 
Brain-derived neurotrophic factor (BDNF), a growth factor, promotes neurogenesis by 
stimulating neuronal proliferation and differentiation (Cotman & Berchtold, 2002).  
The balance of neuronal network activity is the homeostasis of neuronal cell degeneration 
and regeneration. In neurological disorders such as AD, homeostasis is unbalanced and 
degeneration is accelerated, causing an inefficient replacement of depleted cells. This disruption 
causes alterations in the cognitive functions of higher learning, such as memory, reasoning 
behavior, emotional control, and executive function. (Uphold & Graham, 2003). During clinical 
evaluation, the health care provider must consider each of these functions to determine the 







Clinical Presentation and Diagnostics 
According to the American Psychiatric Association (2000), multiple cognitive deficits 
must be present for the diagnosis of AD. To identify the disease progression in a patient, Dr. 
Barry Reisberg, clinical director of New York University’s Aging and Dementia Research 
Center, developed the Functional Assessment Staging (FAST) scale (Table 1), which outlines the 
seven major clinical stages of AD. The staging process identifies common patterns of symptom 
progression from the first sign of memory loss to death, and provides a standard for professionals 
to document the decline of the disease (Reisberg, 1999).  




Normal adult 1 No functional decline. 
Normal older 
adult 
2 Personal awareness of some functional decline. 
Early AD 3 
Mild cognitive impairment (MCI) showing noticeable deficits in 
demanding job situations. 
Mild AD 4 
Assistance required in complicated tasks such as handling 
finances and planning parties. 




Assistance required in dressing, bathing, and toileting. Urinary 
and fecal incontinence progresses. 
Severe AD 7 
Speech ability declines to about a half-dozen intelligible words. 
Progressive loss of abilities to walk, sit up, smile, and hold head 
up. 
(Goetz, 2007). 
To be diagnosed with AD, the onset of the cognitive deficits must be gradual, and a 






loss of memory and at least one other cognitive deficit that interferes with social or occupational 
functioning. As the disease worsens and the patient progresses through each stage, memory 
capacity continues to slowly decline, as do language skills, praxis, and orientation. The patient is 
also unable to learn new information and recall previously learned information. In addition, a 
patient may present with psychiatric symptoms such as depression, psychosis, agitation, and 
personality changes (Smith, 2002).  
By the middle to late stages of the disease, many mental and physical disabilities become 
apparent. Aggression, combativeness, hyperactivity, and disinhibition are the most common 
behavior changes, occurring in 50% of AD patients. Though less common, paranoia, delusions 
and hallucinations can also occur. Physical decline in patients is evident as they develop gait 
imbalance, wandering behaviors, motor disturbances, and incontinence (Smith, 2002). 
Diagnosing AD requires a comprehensive history and examination including the patient’s 
mental and physical states. Specific attention is paid to the patient’s ability to perform daily 
activities and retain recent information. The results will help determine whether further testing is 
needed to make a definitive diagnosis, as well as to rule out differential diagnoses (Uphold & 
Graham, 2003).  
Diagnostic imaging such as computed tomography (CT) scans, magnetic resonance 
imaging (MRI) and positron emission tomography (PET), may play a role in the diagnosis of 
AD. A CT scan can exhibit changes in the brain that are characteristic of AD, including atrophy. 
An MRI can show structural and functional changes in the brain associated with AD. It can also 
help to identify other diagnoses such as tumors and strokes that may cause symptoms of 
dementia. PET scans can help evaluate the progression and may also differentiate AD from other 






Neuropsychological testing can be used to examine the relationship between the brain 
and the patient's behavior. Commonly, these tests are used for patients with memory or 
concentration loss, recollection of words and names, understanding language, visual-spatial 
issues, and a variety of other symptoms. One such test, the Mini-Mental Status Exam (MMSE), 
can help in the diagnosis of conditions that affect thinking, emotion, and behavior such as in AD. 
It can also help recognize additional diagnoses, including depression and anxiety, and cognitive 
problems caused by medicines, substance abuse, strokes, and tumors (U.S. National Institute of 
Health [NIH], 2011).  
Besides the MMSE, other tests are also used in assessing the stage or severity of AD. 
Once the patient is diagnosed with AD through any of the screening tools listed below (Table 2), 
the health care provider can offer options for treatment.  
 
 
TABLE 2: Types of screening tools 
 
Name of Test or Tool Description 
The Mini-Cog (cognitive) Exam  Signs of memory loss and cognitive 
declined is tested. The patient is asked to 
draw a simple clock with the hands 
showing a given time. The patient must 
also attempt to remember and repeat back, 
several unrelated words.  
 
The 7-Minute Neurocognitive Screen To determine if cognitive deterioration is 
caused from normal aging or dementia four 
areas are tested: word recall; date and time 
skills; verbal skills; drawing a clock.  
The Mini-Mental State Exam (MMSE) Skills such as recall, simple calculations, 
and language are assessed. 
Cognitive Abilities Screening Instrument 
(CASI) 
Quantitative assessment is focused on 
attention, concentration, orientation, short-






language abilities, visual construction, list-
generating fluency, abstraction, and 
judgment. 
 
 AD Assessment Scale cognitive subscale 
(ADAS-cog) 
The severity of AD symptoms—memory, 
language, praxis, attention and other 
cognitive abilities—is measured based on 
the completion of 11 tasks.   
 
(Lorentz, Scanlan, & Borson, 2002). 
Pharmacological Management in AD  
While pharmacological treatments stabilize or slow the rate of cognitive decline in mild 
(FAST scale score, four) to moderate AD (FAST scale score, five) patients, the treatments have 
little effect on improving symptoms in the later stages when the neurons are severely damaged. 
Doneprezil (Aricept), Rivastigmine (Exelon), and Galanmine are first-line cholinesterase 
inhibitors used to treat cognitive deficits in patients with mild to moderate AD (Claudio, Bruno, 
Allard, Leon & Florencia, 2010).  
In the AD brain, the amyloid plaques and neurofibrillary tangles destroy cholinergic 
neural cells which transmit acetylcholine, a neurotransmitter involved in cognitive and memory 
functions. The results are a progressive and significant loss of brain function. Treatment using 
cholinesterase inhibitors prevent the action of the acetylcholinesterase to improve levels of 
acetylcholine. By maintaining higher levels of acetylcholine, the drug provides mild and 
temporary improvement in cognition immediately after initiation of the treatment. However, the 
duration of the improvement varies and all patients with AD will continue to decline, despite 
treatment (Claudio et al., 2010).  
The American College of Physicians and The American Academy of Family Physicians 






current research.  The guidelines suggest a need for additional research on the effectiveness of 
pharmacologic management of AD and note that none of the three medications prevent the 
progression of AD (Qaseem et al, 2008). Birks and Flicker (2006) found the positive benefits of 
cholinesterase inhibitors were minor, had a short effect, and had many side effects. The above 
studies found the overall effects of the cholinesterase inhibitors were minute and difficult to 
detect.  
While pharmacological management slows the rate of cognitive decline over the first 12 
months, after three years, the rate of cognitive decline continues and the disease progresses 
(Petersen et al., 2005). Pharmacological therapy provides limited benefit for Alzheimer’s 
treatment. Therefore, more research is needed for improved pharmacological as well as non-
pharmacological strategies that have longer-lasting effects on delaying AD progression. 
The Role of Exercise in AD 
Exercise is a structured physical activity performed with the objective of improving or 
maintaining physical fitness. Physical activity is defined specifically as any “bodily movement 
produced by skeletal muscles that results in energy expenditure and is positively correlated with 
physical fitness” (Caspersen, Powell, & Christenson, 1985). Aerobic exercise involves 
continuous and rhythmic use of large muscles for at least 15 minutes three or more times per 
week, with a 60% increase in resting heart rate. Regular participation in aerobic exercise 
intensifies the heart's capacity to deliver oxygen to vital organs, including the brain (Nelson et 
al., 2007), and is essential to the physiologic mechanisms of the neurological system (Colcombe 
& Kramer, 2003). 
The synapses in the hippocampus can potentially be remodeled by exercise-induced 






2007; Vaynman & Gomez-Pinilla, 2006). Brain-derived neurotrophic factor has been shown to 
stimulate neurogenesis (Kempermann, Kuhn, & Gage, 1998) and has also been found to have a 
crucial role in synaptic transmission, growth, and neuroplasticity (Cotman &Berchtold, 2002). 
Neuroplasticity refers to the brain’s capacity to develop new neuronal and synaptic 
interconnections. As a result, remodeling can occur in particular regions of the brain, specifically 
in the hippocampus and cortex, the area of the brain responsible for learning and memory 
(Cotman & Berchtold, 2002).    
The effects of BDNF protein on AD have been a focus in research for decades. Cotman 
& Berchtold (2002) have found a strong association between physical activity on neuroplasticity, 
neuroprotection, and neurogenesis, processes implicated in the prevention and treatment of AD. 
Decreased levels of amyloid plaques in the frontal cortex, the cortex, and the hippocampus of 
mice, in response to exercise resulted in improvements in cognition, the rate of learning, and an 
increase in growth factor hormones (Adlard, Perreau, & Cotman, 2005). Serum insulin-like 
growth factor 1 (IGF-1), produced in the liver, stimulates the induction of brain-derived 
neurotrophic factor (BDNF) and contributes to hippocampal plasticity and neurogenesis in the 
adult brain. BDNF promotes neurogenesis by stimulating neuronal proliferation and 
differentiation, and increasing the growth of blood vessels and cerebral blood volume, an 
important factor in the neurobiology of exercise (Cotman & Berchtold, 2002). 
A study conducted by Christensen, Marcussen, Wortwein, Knudsen, and Aznar (2008) 
showed injection of beta-amyloid protein (AB) to simulate AD in rats decreased BDNF levels 
and impaired BDNF regulation. The reduction of BDNF seen in AD has been shown to affect the 
hippocampus by weakening synaptic strength and decreasing protection of hippocampal neurons. 






principal cause of the memory problems that characterize this disease (Christensen et al., 2008). 
The observation of reduced BDNF levels  in the AD brains led to the hypothesis that the 
progression of Alzheimer's could be slowed or stopped if brain levels of BDNF could be 
increased (Hof & Morrison, 2004). 
Animal studies can provide information on the effects of exercise on BDNF that is 
challenging to obtain in human studies. A prospective study was conducted on mice by Adlard et 
al. (2005) to determine how age and exercise affect the induction of BDNF across the span of 
life. It was found across all (mice) age groups that BDNF showed a significant increase after 
seven days of exercise. In fact, the oldest age group showed the highest induction of BDNF, 
recognizing the capability of neurogenesis to occur in later life. Results of the animal studies 
suggest that exercise enhances cognitive function  
In humans, routine exercise is associated with an increase in cognitive function, a 
plausible result of increased BDNF levels (Hall, Smith, & Keele, 2001). Pereira et al. (2007) 
found an increase in cerebral blood volume in the hippocampus after individuals participated in 3 
months of an exercise program. The rise of cerebral blood volume was associated with an 
improved performance on a verbal learning and memory test. The increase of cerebral blood 
volume was discovered in the same study which found exercising mice to have an increase in 
neurogenesis, suggesting cerebral blood volume could potentially serve as a biomarker for 
neurogenesis in humans (Pereira et al., 2007). 
Exercise as a Prevention Strategy 
It has long been established that physical exercise is beneficial for a number of age 
related conditions such as osteoporosis, cardiovascular disease, and diabetes mellitus 






health protective benefits on neurological diseases such as AD. A potential health benefit of 
regular exercise in the aging population is the prevention or delay in the loss of cognitive and 
physical function in AD (Booth, Chakravarthy, Gordon, & Spangenburg, 2002). Three forms of 
prevention measures; primary, secondary, and tertiary aim to prevent the onset or progression of 
AD using exercise as a non-pharmacological treatment. 
Primary Prevention  
 It estimated that delaying the onset and progression of dementia for one year would result 
in 9.2 million fewer cases of the disease by 2050 (Brookmeyer, Johnson, Ziegler- Graham and 
Arrighi, 2007). Exercise as a preventative strategy has been effective in protecting young and 
middle-age adults from cognitive decline in their later years (Laurin, Verrault, Lindsay, 
MacPherson and Rockwood, 2001).  
Being more physically active early in life has been found to reduce the risk of developing 
dementia (Rovio, Karehol & Helkala, 2005; Yaffe, Barnes, Nevitt, Lui & Covinsky, 2001), and 
can be a protective tool against the development of the disease (Friedland et al., 2001). When 
compared to their more sedentary peers Rovio, et al.,(2005), Ravaglia et al., (2008), and Larson 
et al., (2006) concluded that elderly people who are more physically active are at less risk of 
developing AD. Moreover, people with higher levels of baseline physical activity are possibly 
less likely to develop cognitive decline (Yaffe, Barnes, Nevitt, Lui and Covinsky, 2001). 
Besides integrating an exercise routine early in life, repeated moderate exercise can be a 
deterrent to AD.  Lifestyle changes, including regular walking have been shown to improve 
memory and cognition and may prevent or slow the cognitive decline associated with AD (Yaffe 
et al.,2001; Ravaglia et al., 2008).  Women who walked at least one and a half hours a week 






week (Weuve,  Kang,  Manson, Breteler, Ware & Grodstein, 2004). Engaging in regular 
moderate activity has been associated with retaining cognitive function (Ravaglia et al.,2008) 
and slowing down cognitive decline in the elderly (Yaffe et al., 2001). 
Secondary Prevention 
 Secondary prevention entails identification of AD in its early stages. This enables the 
health care provider to use interventions such as exercise to treat or manage the disease’s 
progression (USPSTF, 2003). Secondary prevention can be utilized in stage 2 (very mild 
cognitive decline) and stage 3 (mild cognitive impairment). Research has shown that individuals 
with MCI have an increased risk of developing AD within two to three years (AA, 2010; 
Lautenschlager et al., 2008). Consequently, people with MCI may delay or possibly even prevent 
the onset of AD by engaging in physical activity (Yaffe et al., 2001; Middleton, Kirkland, & 
Rockwood, 2008). Lutenschlager et al. (2008) found improved scores on the ADAS-cog 
screening test in elderly with MCI when they participated in 2.5 hours of moderately intense 
exercises over three-50 minute sessions/week for 24 weeks (Lautenschlager et al., 2008). While 
several studies have found a beneficial relationship between exercise and cognition, Middleton et 
al. (2008) questioned whether the intensity of exercise was associated with increased benefits in 
subjects with mild cases of dementia. Those who participated in moderate to high intensity 
exercises were at less risk for further impairment. Collectively, the studies suggest physical 
activity can benefit cognitive function in participants diagnosed at baseline with mild cognitive 
impairment (van Uffelen et al., 2008). 
Tertiary Prevention 
Without appropriate intervention, AD patients will continue to experience cognitive and 






institutionalization, and mortality (Yu, Kolanowski, Strumpf, & Eslinger, 2006). Therefore, 
physical activity as a tertiary intervention can be a useful strategy in therapeutic management. 
The desired outcome of therapeutic management is to prolong functional independence and 
prevent further complications of AD. Exercise has been shown to be an effective intervention 
when the course of neurodegeneration and neuropathology have already occurred (Yu et al., 
2006; Erickson & Kramer, 2008). In a randomized control trial, Rolland et al. (2007) compared 
two groups of patients with mild to moderate AD.  The exercise treatment group participated in a 
one-hour exercise program, consisting of walking, strength training, and balance and flexibility 
twice weekly for 12 months. The control group received routine medical care. Activities of daily 
living (ADL) were assessed using the Katz Index of ADLs. Results suggested a significantly 
slower decline in ADL scores in AD patients who participated in regular exercise than those who 
solely received routine medical care.  
To illustrate the prevention of further functional decline in the latter stages of AD, a 
meta- analysis of studies conducted by Heyn, Abreu, and Ottenbacher (2004) reviewed 30 
randomized trials and found exercise could be beneficial to people with mild to severe AD. The 
participants averaged 3.6 exercise sessions per week with a mean duration of 45 minutes, 
consisting primarily of walking.  The authors concluded that these findings could be useful in 
establishing exercise guidelines for older adults diagnosed with AD. To summarize, physical 
activity as a tertiary intervention can potentially be a useful strategy in therapeutic management. 
Limitations of the Studies  
Although there has been research to show improvements in AD with exercise as an 
intervention, a number of these studies have limitations. The majority of studies reviewed were 






methods and interventions. Age is also a limiting factor simply because of the nature of the 
study. An increased incidence of illness and disease, disabilities, other age-related complications, 
and death led to the reduced number of available participants. Also, the studies lacked a 
homogenous standard of measurement of both exercise (mode, intensity, and duration) and 
cognitive testing. The methods for data collection was also a limiting factor in that many of the 
studies were based on self-reported information from the subjects about their activity levels.  
Consequently, there was a failure to measure specific duration, intensity, and frequency of the 
physical activities. 
Conclusion of the Literature Review 
The studies reviewed the effects of physical activity on cognitive function in animals and 
humans, and show a correlation between exercise and the ability to slow or possibly prevent 
cognitive decline in the elderly. These findings suggest that neurogenesis is active throughout the 
span of life. Researchers (Laurin et al., 2001; Rovio et al., 2005, Ravaglia et al., 2008; 
Lautensclager et al., 2008; Middleton et al., 2008; Yu et al., 2006; Rolland et al., 2007; Heyn et 
al., 2004) have observed that when physical exercise is implemented as a treatment option 
among the elderly, three actions  might occur: the onset of the disease may be prevented through 
primary intervention; the disease may be delayed with secondary intervention; and AD may be 
reversed with tertiary prevention. The research findings can be incorporated into the treatment 
plan and health education of all ages — but specifically, the elderly . 
Educating and Counseling Patients  
Health care providers look for ways to educate and motivate the older adult to overcome 
barriers that prevent them from engaging in regular exercise routines. They can inform older 






they can give guidance on how to incorporate an exercise routine into their daily lives (Ravaglia 
et at., 2008).  
An exercise program should be pleasurable and engaging. Health benefits can be gained 
with short, simple exercises, such as walking.  Understanding the relationship between exercise 
and cognition could provide motivation for healthy older adults to begin an exercise regimen 
(Ravaglia et al., 2008). In patients with moderate to severe AD, Heyn (2003) found using a 
multisensory exercise program that includes physical and cognitive stimuli may decrease resting 
heart rate, increase exercise engagement, and preserve function in patients with AD.  
Implications for Practice  
The USPSTF in 2003 stated there was insufficient evidence to support the need of routine 
screening for dementia in primary care (Boustani, Peterson, Hanson, Harris, & Lohr, 2003). 
However, the American Academy of Neurology recommends routine monitoring and screening 
of patients suspected of cognitive impairment (Petersen et al., 2001). Based on these findings, 
health care providers must decide whether to routinely screen older patients for cognitive 
deficits. Benefits to the 10-minute screening generally result in early detection of the disease, 
which could result in early intervention, lower health care costs, and an enhanced quality of life 
(Weimer & Sager, 2009).  
When health care providers promote lifestyle changes such as routine exercise, they often 
face resistance from the patients. Although benefits of physical exercise for the elderly have been 
well documented, the intimidation of difficult or painful exercise may prevent them from 
beginning an exercise program. Additionally, the provider may stereotype the elderly as 
unwilling to exercise or unable to learn the exercise. Health care providers might also fear that 






include concern over other obligations, inadequate exercise space, self-consciousness, fear of 
injury, or lack of an exercise partner. Health care providers play a role in helping to motivate and 
encourage their patients to engage in healthy behaviors like regular exercise (Elley, Kerse, 
Arroll, & Robinson, 2003).  
At every contact point, providers might want to consider promoting exercise as a 
preventative measure not only for heart disease and other chronic disease, but for AD as well 
(Purcell, Piccinini, & Vallis, 2005). Primary care providers who advised patients about physical 
fitness found a 12% to 50% increase in exercise participation.  To promote exercise as an 
effective strategy, providers could utilize a “green prescription” (Elley et al., 2003; Swinburn et 
al, 1998). A “green prescription” includes a contract on a standard prescription pad which 
includes mode, intensity, and frequency of exercise, in which the patient agrees to participate in 
an exercise program (Elley et al., 2003). Follow-up appointments can be made by phone, and a 
quarterly newsletter can remind patients to maintain their workout regime. Patients who were 
repeatedly reminded over the course of several months were more likely to continue an increased 
activity level than those who were not reminded (Elley et al., 2003). 
Exercise Guidelines for Older Adults 
Health benefits of routine exercise have been well established (e.g., 30 minutes of brisk 
walking at least five days per week). Based on the recommended guidelines, Yaffe et al. (2001) 
found that walking corresponded with a 34% reduction in the risk of developing cognitive 
impairment. Yet, few older adults achieve the daily minimum recommended amount of 30 
minutes of moderately intense activity. The Centers for Disease Control (CDC) surveillance data 






time, household, or transportation physical activity (U.S. Department of Health and Human 
Services [HHS], 2008). 
The 2008 Physical Activity Guidelines for Americans advises older adults to be as 
physically active as their abilities allow (HHS, 2008). In 2008, the HHS published guidelines on 
the amount of physical activity recommended for older adults to maintain their health and fitness 
levels. For significant health benefits, the guidelines recommend most older adults participate in 
at least 150 minutes of moderately intense aerobic activity, 75 minutes of vigorously intense 
aerobic activity, or an equivalent combination of each per week. The American College of Sports 
Medicine (2007) recommends aerobic and muscle-strengthening activity for healthy aging. For 
some patients, low-impact activities such as stretching exercises, swimming, or other water 
activities have been beneficial (Nelson et al., 2007). Presently, there are no exercise guidelines 
specifically for patients with AD; however, Elsawy and Higgins, (2010) found elderly patients 
with chronic illnesses or disabilities gained substantial health benefits when they engaged in non-
strenuous physical activities, such walking. 
AD is one of the most feared illnesses of aging; people are afraid to lose not only their 
independence, but also their quality of life (Larson et al., 2006). Fear of a debilitating disease 
such as AD might motivate older adults, as well as the general public, to incorporate physical 
exercise into their daily routine.   
Recommended Internet Sites  
A document released by a coalition of 50 health organizations was developed to increase 
physical activity among America's aging population, and recommended regular exercise as a 
health benefits for the elderly. The National Blueprint: Increasing Physical Activity Among 






barriers to physical activity, encourages participation by older adults, and outlines strategies for 
increasing physical activity levels. The document contains studies substantiating evidence that 
physical activity can extend years of active independent life, minimize disability, and improve 
the quality of life.  
The World Health Organization Guidelines for Physical Activity of Older Persons/Active 
Ageing (http://www.who.int/ageing/en/) website provides guidelines to explore opportunities for 
health and physical fitness participation to enhance the quality of life in the elderly.  
The Alzheimer’s Disease Education and Referral Center (www.alzheimers.org) is a 
website intended for patients, their family members and caregivers. It provides information on 
AD, drug therapy, and innovative research. The site provides free literature, a search engine for 
health care professionals, and directs families to local support services. 
Alzheimer’s Disease and Related Disorders Association, Incorporated (www.alz.org) 
offers helpful information to health care professionals, patients, and caregivers, and provides 
educational material for AD and related disorders. Local chapters can help caregivers find 
services such as respite programs and day care for AD patients. 
Conclusion  
In summary, numerous research studies have shown a relationship between exercise and 
its positive effect on cognition in the elderly. The primary intervention of regular physical 
activity throughout a person’s life can potentially reduce the likelihood of acquiring AD. 
Screening tools in secondary prevention for early detection and level of progression of AD, 
allows for a targeted method of treatment, such as walking or aerobic exercise. Tertiary 
prevention, through exercise, can enhance quality of life in the later stages of AD by preventing 






preventative measures can be utilized to de-escalate the epidemic of AD. With exercise 
guidelines in place for older adults, healthcare providers can promote lifestyle changes for the 
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